Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 12/20 | 0.70 |
| ▸ | CECR2 | Q9BXF3 | 6/20 | 0.70 |
| ▸ | TAF1 | P21675 | 4/20 | 0.70 |
| ▸ | BRD9 | Q9H8M2 | 4/20 | 0.70 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.70 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.70 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.70 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.70 |
| ▸ | EP300 | Q09472 | 1/20 | 0.70 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.70 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.70 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.70 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17748947 | 0.82 | CECR2 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748918 | 0.78 | TAF1 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748871 | 0.78 | BRD4 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748894 | 0.75 | BRD4 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL27990891 | 0.75 | BRD4 (0.64) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL30306246 | 0.74 | BRD9 (0.74) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748929 | 0.74 | CECR2 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748906 | 0.74 | CECR2 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748926 | 0.74 | BRD4 (1.00) | BRD4CECR2TAF1BRD9TRIM24 | |
| SCHEMBL17748892 | 0.74 | CECR2 (0.73) | BRD4CECR2TAF1BRD9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219939-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023192642-A2 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2023-10-05 | — | — | WO | disclosed |